NCT04286568

Brief Summary

The Wald Outreach Center will partner with Medicine for the Greater Good (MGG) to implement this pilot project called Wald Outreach for Wellness (WOW), a blood pressure outreach wellness intervention in a retail setting.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 27, 2020

Completed
2.9 years until next milestone

Study Start

First participant enrolled

February 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

March 22, 2023

Status Verified

August 1, 2022

Enrollment Period

1 year

First QC Date

February 25, 2020

Last Update Submit

March 20, 2023

Conditions

Keywords

Health DisparitiesOutreachHealth BehaviorUnder-served communities

Outcome Measures

Primary Outcomes (2)

  • Change in actions to control hypertension as assessed by the Behavioral Risk Factor Surveillance System Module 7

    Change in yes/no answers assessed by Behavioral Risk Factor Surveillance System (BRFSS) Module 7. 10 questions graded by yes/no response.

    Assessed at baseline, 6 weeks and 12 weeks

  • Change in blood pressure

    Change in blood pressure (BP) measured in mmHg.

    Assessed at baseline and every 2 weeks, up to 3 months

Secondary Outcomes (3)

  • Change in usage of BP monitor

    Assessed at baseline and every 2 weeks, up to 3 months

  • Change in knowledge of the signs and symptoms of a heart attack and stroke as assessed by BRFSS Module 8

    Assessed at baseline, 6 weeks and 12 weeks

  • Change in engagement with healthcare provider as assessed by BRFSS Section 3

    Assessed at baseline, 6 weeks and 12 weeks

Study Arms (1)

WOW Intervention

EXPERIMENTAL

Participants will receive blood pressure monitor and health passport to record blood pressure readings for 3 months. Participants will receive daily text message reminders to take and record blood pressure readings. Participants will receive health education and health care navigation. Participants will be assessed for social determinants of health. Participants will take surveys 3 times over 3 months. Participants will receive home visits or phone calls to collect data and receive health coaching.

Behavioral: WOW Intervention

Interventions

Health education and coaching, health care navigation,

WOW Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Community residents who participate in Day at the Market
  • Adult individuals 18 years and older whose recorded BP reading is within the pre-hypertensive range 120-139 systolic; 80-89 diastolic
  • Able to read and understand English

You may not qualify if:

  • years or younger
  • BP reading above pre-hypertensive range
  • Unable to read and understand English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins University School of Nursing

Baltimore, Maryland, 21205, United States

Location

MeSH Terms

Conditions

PrehypertensionHypertensionHealth Behavior

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesBehavior

Study Officials

  • Catherine Ling, PhD, FNP-BC

    Johns Hopkins University School of Nursing

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: quasi-experimental non-randomized
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2020

First Posted

February 27, 2020

Study Start

February 1, 2023

Primary Completion

February 1, 2024

Study Completion

February 1, 2024

Last Updated

March 22, 2023

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations